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Abstract The interaction of VacA with membranes involves: (i)
a low pH activation that induces VacA monomerization in
solution, (ii) binding of the monomers to the membrane, (iii)
oligomerization and (iv) channel formation. To better understand
the structure^activity relationship of VacA, we determined its
topology in a lipid membrane by a combination of proteolytic,
structural and fluorescence techniques. Residues 40^66, 111^169,
205^266, 548^574 and 723^767 were protected from proteolysis
because of their interaction with the membrane. This last peptide
was shown to most probably adopt a surface orientation. Both
K-helices and L-sheets were found in the structure of the
protected peptides. ß 2000 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
The toxin VacA produced by pathogenic Helicobacter py-
lori strains is a major virulence factor in human gastroduode-
nal diseases [1^5]. The protein is synthesized as a 140 kDa
precursor from which a 40 kDa C-terminal domain necessary
for extracellular secretion is removed on the bacterial surface
[6]. The mature protein (95 kDa) is found both at the bacterial
cell surface and in the extracellular medium. This 95 kDa
protein puri¢ed from the supernatants of H. pylori frequently
contains two fragments of 37 kDa (p37 residues N-ter-319)
and 58 kDa (p58 residues 320-C-ter) [6]. The full length pro-
tein that is released by the bacteria is a low activity complex
formed by up to 12 monomers (Fig. 1.1) [6,7]. This complex
can be activated by a low pH treatment which most probably
results in oligomer disassembly (Fig. 1.2) [7,8]. The treatment
of cells with activated VacA leads to the formation in the cell
cytoplasm of large V-ATPase-, rab 7- and Igp-positive vacu-
oles originating from late endosomal and lysosomal compart-
ments [9] and to a vacuolation-independent permeability in-
crease of polarized epithelial monolayers [10,11]. Recently, it
has been demonstrated that low pH-activated VacA was able
to induce anion-selective channels in planar lipid bilayers and
HeLa cells plasma membrane [12,13]. The increased perme-
ability of the plasma membrane of gastric epithelial cells by
VacA might help H. pylori colonization of the stomach by
allowing the e¥ux of potential metabolic substrates such as
pyruvate and HCO33 . Whether vacuolation is a late conse-
quence of the channel formation or the consequence of a
cytoplasmic interaction between VacA, or a VacA domain,
and a still non-identi¢ed target remains to be determined.
The pH dependence of VacA-induced vacuolation reveals
that maximum activity is reached slightly below pH 5.0 and
remains stable down to pH 2 [14]. Using sucrose gradient
centrifugation it was demonstrated that, at pH 5.0, the protein
undergoes a transition from an oligomeric to a monomeric
structure [14]. This transition was characterized by exposure
at the surface of the protein of hydrophobic sites, as evidenced
by binding of ANS, a £uorescent hydrophobic probe [14].
Binding of VacA to lipid vesicles was also maximum at pH
5.0 and was characterized by the formation of hexameric
pores in the lipid membrane [15]. Furthermore, activation at
a mild acidic pH leads to a deep insertion of VacA in the lipid
membrane as demonstrated by labeling by hydrophobic pho-
toactivatable lipid probes [16]. The current model that is pro-
posed for the interaction of VacA with the membrane involves
(i) a low pH activation that induces a VacA monomerization
in solution (Fig. 1.2), (ii) binding of the monomers to the
membrane (Fig. 1.3), (iii) oligomerization (Fig. 1.4) and (iv)
channel formation (Fig. 1.5). To better understand the struc-
ture^activity relationship of VacA, we have probed the topol-
ogy of this protein inserted at pH 5.0 in liposomes by pro-
teolysis and £uorescence studies. The secondary structures of
the membrane peptides were determined by Fourier transform
infrared spectroscopy (FTIR).
2. Materials and methods
2.1. Materials
Proteinase K (PK) and asolectin (mixed soybean phospholipids)
were obtained from Sigma (St. Louis, MO, USA). Phenylmethylsul-
fonyl £uoride (PMSF) was from Serva. Polyvinylidene di£uoride
(PVDF; problott) membranes were obtained from Applied Biosys-
tems, and acrylamide was from Bio-Rad. All other reagents were of
the highest purity available.
2.2. Protein puri¢cation
VacA from H. pylori strain CCUG 17847 was puri¢ed from the
broth culture supernatants as described in [17]. For all experiments,
the protein was puri¢ed by gel ¢ltration on a Superose 6 column in
2 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES),
2 mM NaCl, pH 7.2 and stored at 4‡C.
2.3. Liposome preparation
Asolectin was puri¢ed according to the method of [18] and kept as
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a stock solution in chloroform (100 mg/ml). A ¢lm of lipids was
formed on a glass tube under a nitrogen £ux. This ¢lm was rehydrated
in a 20 mM HEPES, 150 mM NaCl, pH 7.2, bu¡er. Large unilamellar
vesicles (LUV) were formed by an extrusion procedure (pores: 0.1 Wm
diameter) at room temperature according to [19]. The concentration
of lipids was determined by measuring the lipid phosphorus content
[20].
2.4. Preparation of VacA proteoliposomes
300 Wg of VacA was mixed with LUV (VacA/LUV, 1/10, w/w in a
¢nal volume of 350 Wl) in a 20 mM HEPES, 150 mM NaCl, bu¡er at
pH 7.2, and incubated for 10 min at 37‡C. The pH was then lowered
to pH 5.0 by addition of a predetermined volume of 1 M sodium
acetate (NaAc), pH 5.0. Under these conditions, 100% of VacA was
inserted into the liposomes [21]. After 10 min of incubation at 37‡C,
the sample was run on a 30^2% sucrose gradient as described in
[22] and the protein and lipid distributions along the gradient were
determined, respectively, by measuring Trp £uorescence (Vex = 280 nm
and Vem = 340 nm) and by choline dosage (Test combination phos-
pholipids, Boehringer Mannheim Biochemia). Fractions which
contained both lipids and proteins were pooled, centrifuged and
washed twice to remove the sucrose with (i) a 2 mM HEPES, 2 mM
NaCl, pH 5.0, bu¡er (FTIR experiments) or (ii) a 20 mM NaAc,
150 mM NaCl, pH 5.0, bu¡er (PK experiments) or (iii) a 20 mM
Tris, 150 mM NaCl, 2 mM EDTA, pH 7.0 bu¡er (cysteine binding
to N-[6-(7-amino-4-methylcoumarin-3-acetamido)hexyl]-3P-(2P-pyridyl-
dithio)propionamide (AMCA-HPDP)).
2.5. Proteolysis of VacA proteoliposomes by PK
To determine the proteolysis conditions, a freshly prepared stock
solution of PK (5 mg/ml) was added to the VacA proteoliposomes
prepared as previously described (VacA 0.6 mg/ml, PK/VacA, 1/1,
w/w). CaCl2 was added at a ¢nal concentration of 2 mM. The incu-
bation was carried out at 37‡C for time periods of 1, 5, 10, 24 and
48 h. The digestion was stopped by addition of 2 mM PMSF. The
sample was then mixed with an equal volume of 80% sucrose, and
overlaid with a 30^2% linear sucrose gradient. After an overnight
centrifugation at 125 000Ug at 4‡C (Beckman L7 ultracentrifuge,
SW60 rotor), the proteoliposomes were recovered and centrifuged
twice in a 2 mM HEPES, 2 mM NaCl, bu¡er at pH 5.0 to remove
the sucrose. The digested samples were delipidated [23] and run either
on a 5^20% acrylamide gradient gel electrophoresis (sample bu¡er:
62 mM Tris^HCl, pH 6.8, bu¡er, 2% sodium dodecyl sulfate (SDS),
10% glycerol (w/v) and 0.01% bromophenol blue) [24] or a Tris^Tri-
cine SDS^polyacrylamide gel electrophoresis (PAGE) (16.5% com-
bined acrylamide and bisacrylamide (T), 6% of which is crosslinker
(bisacrylamide, C) [25]. To prepare the samples for N-terminal se-
quencing and structural analysis, the VacA proteoliposomes were di-
gested at a PK/VacA ratio of 1/1 (w:w) at 37‡C for 48 h. The peptides
N-terminal amino acid sequence was determined as described in [23].
2.6. Cysteine labeling
Binding of the £uorescent probe AMCA-HPDP (1 mg/ml in di-
methyl sulfoxide) was performed at pH 7.0 on VacA in solution
and VacA reconstituted in lipid vesicles, before and after proteolysis
and in the absence or presence of a reducing agent according to [23].
The reduction step was carried out for 2 h in the presence of a
100-fold excess of dithiothreitol (DTT) in a 20 mM Tris, 150 mM
NaCl, 2 mM EDTA, pH 7.0 bu¡er. The reducing agent was removed
by centrifugation of the samples through a G50 mini-column. The
protein was labeled with a 20-fold molar excess of AMCA-HPDP
for 1 h at room temperature and when proteoliposomes were in-
volved, 0.15% Triton X-100 was added to the sample. In all cases,
the unreacted AMCA-HPDP and detergent were eliminated by gel
¢ltration on a G50 mini-column equilibrated with 0.1% SDS in water.
The £uorescence associated with VacA was measured with an SLM
8000 spectro£uorimeter (Vex = 345 nm; Vem = 450 nm), and the protein
concentration was determined by Trp £uorescence using a standard
curve obtained with VacA in 0.1% SDS.
2.7. IR spectroscopy
Attenuated total re£ection infrared spectra (resolution of 4 cm31)
were obtained with a Perkin-Elmer 1720X FTIR spectrophotometer
as previously described [26]. Measurements and sample deuteration
were carried out as described in [27,28]: hydrogen/deuterium exchange
allows di¡erentiation of the K-helix from the random structure, whose
absorbance bands shift from about 1655 to about 1642 cm31. The
determination of the secondary structure of proteins was carried out
by analysis of the deuterated amide I region as described previously
[27]. The frequency limits for the di¡erent structures were as follows:
1662^1645 cm31, K-helix; 1689^1682 cm31 and 1637^1613 cm31,
L-sheet; 1645^1637 cm31, random coil ; and 1682^1662 cm31, L-turns.
The control spectra of the 2 mM HEPES bu¡er, pH 7.2, and asolectin
vesicles at both pH 5.0 showed no absorbance between 1700 and
1600 cm31 (data not shown).
3. Results
Proteoliposomes containing VacA inserted in the membrane
were prepared by incubating the protein with LUVs of aso-
lectin at low pH. The lipid-bound protein was separated from
the non-associated protein by centrifugation on a sucrose gra-
dient. To determine the regions of VacA protected from a
protease because of their association to the membrane,
VacA proteoliposomes were treated with a non-speci¢c pro-
tease, PK. Digestion was performed at 37‡C at a PK/VacA
ratio of 1/1 (w/w) from 0 to 48 h, and the samples were
analyzed by electrophoresis on a 5^20% gradient SDS^
PAGE gel. After 48 h, no full length protein was detectable
on the gel (Fig. 2). Instead, a large band, most probably
containing several proteolysed peptides was observed at the
bottom of the gel. A sample obtained after 48 h of digestion
was therefore run on a Tris^Tricine electrophoresis gel (16.5%
T, 6% C) which should allow the resolution of peptides from
2 to 20 kDa [25]. Even under these conditions, the bands were
not fully resolved and the molecular weights of the peptides
ranged from 13 to about 3 kDa (data not shown). These
Fig. 1. Schematic representation of VacA mechanism of interaction with a lipid membrane.
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bands were transferred onto a PVDF membrane which was
sliced into six zones in the region containing the peptides. The
N-terminal amino acid sequence analysis was then applied to
these six samples (Table 1). Each sample contained more than
one peptide. In total, ¢ve N-terminal moieties were identi¢ed:
N39 (or K40), T111, L205, S548 and N723. The approximate
C-terminal boundaries of the protected regions were evaluated
from the smallest obtained peptides, according to their appar-
ent molecular weights as determined from the gel (about 3 kDa
for peptides N39, K40 and S548, about 5 kDa for peptide
N723 and about 6 kDa for the other ones). The higher mo-
lecular weight peptides most probably correspond to partial
digestion. The minimal protected sequences are reported on
the VacA sequence in Fig. 3. Three nearby protected regions
(residues 40^66, 111^169 and 205^266) are located at the
Fig. 2. Proteolysis of VacA proteoliposomes. Silver staining of a
5^20% gradient SDS^PAGE gel. A: 5 Wg of VacA reconstituted in
LUV as described in Section 2. B: VacA proteoliposomes (300 Wg
VacA) treated for 48 h by PK as described in Section 2. P indicates
the presence of several unresolved peptides.
Table 1
N-terminal sequences of the protected peptides
Molecular
weight (kDa)
Band N-terminal sequence
12.8 A1 40KTPDKPDKVWRIQAGKGFNEF
A2 39NKTPDKPDKVWRIQAGKGFNEF
A3 205LYDGATLNLASSS
A4 548SRINTVRLETGTRSLFSG
A5 723NVNLEEQFKERLALYN
10.4 B1 40KTPDKPDKVWRIQAGKGFNEF
B2 39NKTPDKPDKVWRIQAGKGFNEF
B3 723NVNLEEQFKERLALYN
B4 548SRINTVRLETGTRSLFSG
8.4 C1 723NVNLEEQFKERLALYN
C2 40KTPDKPDKVWRIQAGKGFNEF
C3 39NKTPDKPDKVWRIQAGKGFNEF
C4 548SRINTVRLETGTRSLFSG
C5 111TLSGLRNFTGGDLDVNM
C6 205LYDGATLNLASSS
6.4 D1 723NVNLEEQFKERLALYN
D2 40KTPDKPDKVWRIQAGKGFNEF
D3 39NKTPDKPDKVWRIQAGKGFNEF
D4 548SRINTVRLETGTRSLFSG
D5 111TLSGLRNFTGGDLDVNM
D6 205LYDGATLNLASSS
About 5 E1 723NVNLEEQFKERLALYN
E2 40KTPDKPDKVWRIQAGKGFNEF
E3 39NKTPDKPDKVWRIQAGKGFNEF
About 3 F1 548SRINTVRLETGTRSLFSG
F2 40KTPDKPDKVWRIQAGKGFNEF
F3 39NKTPDKPDKVWRIQAGKGFNEF
Fig. 3. Localization in the VacA sequence of the protected peptides.
The arrow indicates the N-terminal moiety determined by N-termi-
nal sequencing. The C-terminal residues are de¢ned on the basis of
the apparent molecular weights of the peptides, as determined by
electrophoresis on a Tris^Tricine gel (16.5% T, 6% C).
Fig. 4. Binding of AMCA-HPDP to soluble (A) or membrane-asso-
ciated VacA without (B) or with (C) proteolysis. A and B: the con-
centration of VacA was determined as described in Section 2.
(a) Absence of DTT; (b) reduction with DTT. All £uorescence mea-
surements were performed in 0.1% SDS (see Section 2). Four, three
and two experiments were carried out, respectively, in A, B and C.
FEBS 24090 8-9-00
X.-M. Wang et al./FEBS Letters 481 (2000) 96^10098
N-terminal moiety of the protein. They are followed by a long
unprotected domain (from about residue 264 to 547). Two
protected peptides are identi¢ed at the C-terminal extremity
of the protein (residues 548^574 and 723^767).
The proteolytic approach permits the identi¢cation of pep-
tides that are tightly bound to a lipid membrane but does not
formally provide information about the transmembrane or
surface orientation of these peptides. We took advantage of
the presence of two cysteine residues in VacA (Cys746 and
Cys757) to provide data on the membrane topology of the
protected peptide 723^767. We investigated this topology by
measuring the binding of the probe AMCA-HPDP to the
protein. This £uorescent probe binds to free thiols. The
amount of bound AMCA-HPDP was determined by the pro-
tein £uorescence (Vex = 345 nm; and Vem = 450 nm) after re-
moval of the unbound probe. In the absence of DTT, AMCA
binds to VacA in solution at neutral pH (Fig. 4A). This bind-
ing is increased upon addition of DTT to the suspension sug-
gesting the presence of two populations of VacA, character-
ized by the presence, or absence, of a disul¢de bridge:
according to the £uorescence data, about 40% of the VacA
molecules do not contain this bridge. Addition of a denatur-
ing concentration of guanidine hydrochloride (6 M) did not
increase the signal obtained in the presence of DTT (not
shown) suggesting that all Cys residues are located at the
surface of the protein. VacA proteoliposomes were then pre-
pared at pH 5.0 as previously described and washed in a Tris
bu¡er at pH 7.0. Fig. 4B shows that the binding of AMCA to
proteoliposomes in the absence or presence of DTT was qual-
itatively similar to that observed in solution. Similar results
were obtained with the VacA proteoliposomes treated by PK
(Fig. 4C). In the last two cases, the addition of Triton X-100
to disrupt the liposomes prior to AMCA binding did not
increase the £uorescence obtained in the presence of DTT
(data not shown). This strongly suggests that the Cys residues
of lipid-bound VacA and of peptide 723^767 are fully acces-
sible to AMCA-HPDP and that the protected peptide 723^
767 adopts a surface orientation.
According to the FTIR spectroscopy analysis of VacA, this
protein contains 24 þ 5% and 35 þ 5% of K-helices and
L-sheets, respectively [21]. The FTIR spectroscopy is based
on the analysis of the vibration bands of protein and partic-
ularly the X(CNO) of the peptidic bond (amide I band),
whose frequency of absorption is strongly dependent upon
the secondary structure. It was used here to determine the
secondary structure of the membrane-protected peptides.
Fig. 5 shows the deuterated spectra of proteoliposomes of
VacA before and after digestion with PK. After digestion,
the surface ratio of amide I/lipid X(CNO) decreased, which
con¢rms the removal of most of the VacA residues. Fig. 5,
inset, gives the spectrum in the amide I region of the digested
sample. It is characterized by absorption maxima at 1635
cm31 (L-sheet) and 1654 cm31 (K-helix). The percentages of
secondary structures for intact and proteolysed lipid-bound
VacA are, respectively, 24 and 30% of K-helix, 35 and 44%
of L-sheets, 18 and 15% of random coils and 23 and 11% of L-
turns.
4. Discussion
To provide further information on the structure^activity
relationship of VacA, we aimed at determining the mem-
brane-associated regions of the protein as well as their struc-
ture. When a non-speci¢c protease was added to VacA pro-
teoliposomes, a ¢rst group of protected peptides covers
residues 40^66, 111^169 and 205^266 indicating that the N-
terminal region of VacA has a strong tendency to interact
with the membrane. This N-terminal region is responsible
for several properties of VacA:
b Formation of water-soluble oligomeric structures (Fig. 1.1):
short deletions between residues 28 and 294 lead to mole-
cules unable to oligomerize in water [29].
b Channel formation: full length VacA induces channel for-
mation but neither the N-terminal (p37) nor the C-terminal
(p58) alone are responsible for this property suggesting that
domains from the two subunits are essential for channel
formation [10,13].
b Vacuolation: the minimal vacuolating domain has been lo-
calized between residues 1 and 422. Any N-ter, C-ter or
internal deletions of this region leads to a VacA protein
devoid of its vacuolating activity [29^31].
Channel formation is one of the most likely steps that
would require the insertion of protein domains in the lipid
membrane and it is therefore tempting to suggest that the
protected peptides 40^66, 111^169 and 205^266 play a role
in channel formation. A special mention should be made of
residues 6^27. Based on the hydrophobicity of this region, it
was suggested that it could interact with the membrane. A
VacA mutant deleted of residues 6^27 induces channel forma-
tion with a conductance identical to the WT protein but at a
slower rate and with a modi¢ed selectivity [29]. The lipid-
binding properties as well as the ability to oligomerize into
the lipid membrane (Fig. 1, steps 3 and 4) of this mutant are
unaltered [29]. This indicates that residues 6^27 might not be
essential for membrane insertion and regulate the channel
properties by an unknown mechanism. Our proteolysis data
Fig. 5. Infrared spectra of deuterated VacA proteoliposomes (A) be-
fore and (B) after proteolysis carried out as described in Section 2.
Inset: Amide I region corresponding to spectrum b (a) without and
(b) with deconvolution (resolution factor 2).
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provide a further indication that residues 6^27 are indeed not
membrane associated.
As discussed above, the N-terminal region of VacA is nec-
essary but not su⁄cient to induce channel formation. Two
additional protected peptides were found at the C-terminal
moiety between residues 548 and 574 and residues 723 and
767. The last peptide is most probably associated to the sur-
face of the lipid membrane, according to the accessibility of
Cys 746 and 757 to the £uorescent probe AMCA-HPDP.
Whether the two peptides are associated to channel formation
is unclear. Binding properties have been associated to the
C-terminal of VacA: antibodies reactive to amino acids
479^803 inhibit VacA binding to cells [32]. We cannot, there-
fore, exclude that association of the C-terminal protected pep-
tides to the membrane could be related to cell surface binding
instead of, or in addition to, channel formation.
We previously demonstrated that the secondary structure of
VacA was independent of the pH and the presence of a lipid
membrane. This structure contains 24 þ 5% and 35 þ 5% of
K-helices and L-sheets, respectively [21]. The proportion of
K-helix and L-sheets increased in the proteolysed sample sug-
gesting that the peptides protected by the lipid membrane are
highly organized and contain both types of structure. A sim-
ilar observation has been made for diphtheria toxin, an A-B
type toxin in which the N-terminal part of the B domain,
which carries the channel-forming domain, interacts with the
membrane through K-helices and the C-terminal moiety, car-
rying the receptor binding site via L-sheets [23,33].
In conclusion, we have localized the domains of VacA pro-
tected from an externally added protease by their interaction
with a lipid membrane. Peptides from both the N- and
C-terminus of VacA have been identi¢ed and both K-helix
and L-sheet structures are found within these peptides. Fur-
ther work will have to be carried out to understand the role of
these peptides in cell binding, vacuolation and channel forma-
tion of VacA but this study provides a good basis for site-
directed mutagenesis studies.
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